Company profile
Therapanacea Sas
Therapanacea Sas has 4 AI-enabled medical devices on the FDA list. The first decision was on April 19, 2023 and the most recent on December 23, 2025 (ART-Plan+ (v3.1.0)). Its most common review panel is Radiology (4 devices).
4AI devices
2023First decision
2025Latest decision
1Specialties
Per year
202320242025
By specialty
Related guides
Timeline
- ART-Plan+ (v3.1.0) · Radiology · MUJ
- ART-Plan+ (v.3.0.0) · Radiology · MUJ
- ART-Plan (v.2.2.0) · Radiology · MUJ
- ART-Plan · Radiology · QKB